Empowered Patient Podcast

Kirby Brady, Director Research, San Diego Regional Economic Development Corp. shares recent research about the abundance of healthcare and pharmaceutical companies, research institutions, medical device developers, and artificial intelligence and big data experts that have made San Diego a world-renowned hub of precision health. The report also reveals the number of start-ups that have been created to translate basic research into functional digital health solutions.

@SDRegionalEDC

PrecisionHealthSD.com

Jesús Martin-Garcia, CEO, GeNeuro discusses the need for new treatment approaches for multiple sclerosis (MS), a long lasting, often disabling disease of the central nervous system that affects 2.5 million people worldwide. GeNeuro is developing a potential new approach for treating disease progression, the largest unmet medical need in MS, by seeking to block mechanisms suspected of driving neurodegeneration.

#MultipleSclerosis #MS $GNRO

GeNeuro.com

Dr. Patrik De Haes, CEO, Oxurion discusses the need for new treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide. About half of patients living with diabetic eye disease respond poorly or do not respond at all to the current standard of care. Oxurion is working to advance its clinical development and is partnering with advocacy groups around the world to increase patients' access to potential therapies.

@Oxurion

Oxurion.com

Elad Kedar, CEO, Orasis discusses CSF-1, the company's corrective eye drop being developed for the treatment of presbyopia as an alternative to reading glasses. Presbyopia, the inability to focus on near objects, is common after the age of 40 and affects more than 1.8 billion people worldwide. While glasses have been used for hundreds of years to correct vision, ophthalmologists are excited about these innovative eye drops that will change eye care.

Orasis-Pharma.com

Dr. Chorom Pak, President and CEO, LynxBio was a finalist in the John G. Watson Quick Pitch Competition presented by the Tech Coast Angels and the San Diego Venture Group. She talks about using an advanced approach to diagnosing cancer by using a standard-of-care biopsy to create a living model of a patient's cancer, including the patient's own microenvironment, to rapidly identify effective treatment options.

@lynxbio

@TCASanDiego

@SDVG

Lynx Biosciences

Shiv Shukla, Founder and CEO, NeuraLace Medical is a healthcare entrepreneur with a passion for finding a new treatment for managing chronic neuropathic pain and the winner of the John G. Watson Quick Pitch Competition presented by the Tech Coast Angels and San Diego Venture Group. Their Axon Therapy is currently being tested with the VA where patients receive recurring non-invasive treatments that have dramatically reduced the need for opioids for chronic pain.

#QuickPitch18

@TCASanDiego

@SDVG

NeuraLace Medical

Alex Ovadia, CEO, Check-Cap discusses C-Scan® the first and only preparation-free screening method for the prevention of colorectal cancer (CRC) through the detection of pre-cancerous polyps. This patient-friendly screening method uses an ingestible x-ray capsule and has the potential to dramatically increase screening adherence and reduce the overall incidence of CRC.

@CheckCap_

Check-Cap

Avanish Vellanki, Co-Founder and CEO, Rain Therapeutics talks about developing targeted therapies for patients across a range of cancers. Their lead program tarloxotinib is currently being developed for non-small cell lung cancer patients with EGFR/Exon 20 mutations. Avanish fills us in on what makes tarloxotinib so unique, how it has the potential to help patients who currently have no viable treatment options and the future of precision medicine in treating cancers.

@Rain_Thera

Rain Therapeutics

Joanne Jarrett MD is a retired family physician, blogger, mom, wife and entrepreneur and talks with me about her provocative blog post Three Ways We May Be Teaching Our Kids To Be Liars. Joanne points out that dishonesty is a misguided short-cut when attempting to avoid hurt feelings and that kids need to learn to balance kindness and social grace with authentic response to actions. This includes telling the truth about bullying, medical conditions, and life style choices in conversations about socially acceptable behavior versus accuracy of feelings.

CozyClothesBlog.com

Gilead Raday, COO, RedHill Biopharma discusses development of the next generation of effective therapies for gastrointestinal disorders and cancer that affect millions of people worldwide. This includes treatment for H. pylori infections which can cause ulcers and gastric cancer, the first-ever therapy for Crohn's disease that targets the hypothesized bacterial cause of the disorder, and additional therapies for IBS-D and gastroenteritis.

@RedHillBio

RedHill Biopharma